{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0093-5528",
      "generic_name": "Atazanavir Sulfate",
      "labeler_name": "Teva Pharmaceuticals USA, Inc.",
      "brand_name": "Atazanavir Sulfate",
      "active_ingredients": [
        {
          "name": "ATAZANAVIR SULFATE",
          "strength": "300 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0093-5528-56",
          "description": "30 CAPSULE in 1 BOTTLE (0093-5528-56)",
          "marketing_start_date": "20171227",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Teva Pharmaceuticals USA, Inc."
        ],
        "rxcui": [
          "402246",
          "402247",
          "664741"
        ],
        "spl_set_id": [
          "654b7e08-33d8-47e7-b37f-3681e79c7b8b"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "4MT4VIE29P"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "CAPSULE",
      "spl_id": "61209ea1-63c7-43fc-ac32-d840a8a0906a",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20171227",
      "product_id": "0093-5528_61209ea1-63c7-43fc-ac32-d840a8a0906a",
      "application_number": "ANDA091673",
      "brand_name_base": "Atazanavir Sulfate",
      "pharm_class": [
        "Cytochrome P450 2C8 Inhibitors [MoA]",
        "Cytochrome P450 3A Inhibitors [MoA]",
        "Cytochrome P450 3A4 Inhibitors [MoA]",
        "HIV Protease Inhibitors [MoA]",
        "Protease Inhibitor [EPC]",
        "UDP Glucuronosyltransferases Inhibitors [MoA]",
        "UGT1A1 Inhibitors [MoA]"
      ]
    }
  ]
}